Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-Term Glucocorticosteroid Optimization in Chronic Recurrent DILI
NCT03266146Phase 2Completed
- Sponsor
- The Fifth Medical Center of the PLA General Hospital
- Start
- Sep 2017
- Primary completion
- Jan 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone in drug induced liver injury (DILI), sponsored by The Fifth Medical Center of the PLA General Hospital. Started Sep 2017; status: completed.
02
Drugs
methylprednisolone
03
Conditions
drug induced liver injury (DILI)
Beyond the preview
Go deeper on NCT03266146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03266146.